Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno M D C Godinho

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Molecular Therapy. Nucleic Acids|January 16, 2026
The 2025 Oligo Meeting in Budapest: Highlights of the 21<sup>st</sup> annual meeting of the oligonucleotide therapeutics societyBruno M D C Godinho, Shuling Guo
Methods in Molecular Biology (Clifton, N.J.)|February 25, 2022
Intrathecal Delivery of Therapeutic Oligonucleotides for Potent Modulation of Gene Expression in the Central Nervous SystemZachary Kennedy, James W Gilbert, Bruno M D C Godinho
Drug Discovery Today|September 27, 2014
Delivering a disease-modifying treatment for Huntington's diseaseBruno M D C Godinho, Meenakshi Malhotra, Caitriona M O'Driscoll, et al.
Plos One|October 3, 2012
Adenoviral delivery of angiotensin-(1-7) or angiotensin-(1-9) inhibits cardiomyocyte hypertrophy via the mas or angiotensin type 2 receptorMonica Flores-Muñoz, Bruno M D C Godinho, Abdulaziz Almalik, et al.
Journal of Pharmaceutical Sciences|July 30, 2013
Non-viral nanosystems for gene and small interfering RNA delivery to the central nervous system: formulating the solutionAoife M O'Mahony, Bruno M D C Godinho, John F Cryan, et al.
Molecular Pharmaceutics|November 3, 2012
Self-assembling modified β-cyclodextrin nanoparticles as neuronal siRNA delivery vectors: focus on Huntington's diseaseBruno M D C Godinho, Julien R Ogier, Raphael Darcy, et al.
Molecular Biosystems|July 3, 2015
RNAi therapeutics for brain cancer: current advancements in RNAi delivery strategiesMeenakshi Malhotra, André Toulouse, Bruno M D C Godinho, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 24, 2015
Synthesis and characterization of rabies virus glycoprotein-tagged amphiphilic cyclodextrins for siRNA delivery in human glioblastoma cells: in vitro analysisMatt Gooding, Meenakshi Malhotra, David J McCarthy, et al.
International Journal of Pharmaceutics|July 4, 2014
PEGylated cyclodextrins as novel siRNA nanosystems: correlations between polyethylene glycol length and nanoparticle stabilityBruno M D C Godinho, Julien R Ogier, Aoife Quinlan, et al.
Nucleic Acids Research|June 8, 2017
5΄-Vinylphosphonate improves tissue accumulation and efficacy of conjugated siRNAs in vivoReka A Haraszti, Loic Roux, Andrew H Coles, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Molecular Therapy. Nucleic Acids|January 16, 2026
The 2025 Oligo Meeting in Budapest: Highlights of the 21<sup>st</sup> annual meeting of the oligonucleotide therapeutics societyBruno M D C Godinho, Shuling Guo
Methods in Molecular Biology (Clifton, N.J.)|February 25, 2022
Intrathecal Delivery of Therapeutic Oligonucleotides for Potent Modulation of Gene Expression in the Central Nervous SystemZachary Kennedy, James W Gilbert, Bruno M D C Godinho
Drug Discovery Today|September 27, 2014
Delivering a disease-modifying treatment for Huntington's diseaseBruno M D C Godinho, Meenakshi Malhotra, Caitriona M O'Driscoll, et al.
Plos One|October 3, 2012
Adenoviral delivery of angiotensin-(1-7) or angiotensin-(1-9) inhibits cardiomyocyte hypertrophy via the mas or angiotensin type 2 receptorMonica Flores-Muñoz, Bruno M D C Godinho, Abdulaziz Almalik, et al.
Journal of Pharmaceutical Sciences|July 30, 2013
Non-viral nanosystems for gene and small interfering RNA delivery to the central nervous system: formulating the solutionAoife M O'Mahony, Bruno M D C Godinho, John F Cryan, et al.
Molecular Pharmaceutics|November 3, 2012
Self-assembling modified β-cyclodextrin nanoparticles as neuronal siRNA delivery vectors: focus on Huntington's diseaseBruno M D C Godinho, Julien R Ogier, Raphael Darcy, et al.
Molecular Biosystems|July 3, 2015
RNAi therapeutics for brain cancer: current advancements in RNAi delivery strategiesMeenakshi Malhotra, André Toulouse, Bruno M D C Godinho, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 24, 2015
Synthesis and characterization of rabies virus glycoprotein-tagged amphiphilic cyclodextrins for siRNA delivery in human glioblastoma cells: in vitro analysisMatt Gooding, Meenakshi Malhotra, David J McCarthy, et al.
International Journal of Pharmaceutics|July 4, 2014
PEGylated cyclodextrins as novel siRNA nanosystems: correlations between polyethylene glycol length and nanoparticle stabilityBruno M D C Godinho, Julien R Ogier, Aoife Quinlan, et al.
Nucleic Acids Research|June 8, 2017
5΄-Vinylphosphonate improves tissue accumulation and efficacy of conjugated siRNAs in vivoReka A Haraszti, Loic Roux, Andrew H Coles, et al.
Pageof 4